Analyzing Allstate's Stock Performance – A Brief Overview

By Susan Ramirez • Wednesday, June 25 10:01 • Permanent Link

Allstate logged a -0.9% change during today's morning session, and is now trading at a price of $194.24 per share. The S&P 500 index moved 0.0%. ALL's trading volume is 77,900 compared to the stock's average volume of 1,621,956.

Allstate trades -14.66% away from its average analyst target price of $227.59 per share. The 17 analysts following the stock have set target prices ranging from $149.0 to $286.0, and on average have given Allstate a rating of buy.

Anyone interested in buying ALL should be aware of the facts below:

Allstate's current price is 11.0% above its Graham number of $174.95, which implies that at its current valuation it does not offer a margin of safety
Allstate has moved 23.8% over the last year, and the S&P 500 logged a change of 11.2%
Based on its trailing earnings per share of 14.64, Allstate has a trailing 12 month Price to Earnings (P/E) ratio of 13.3 while the S&P 500 average is 29.3
ALL has a forward P/E ratio of 10.2 based on its forward 12 month price to earnings (EPS) of $19.03 per share
Its Price to Book (P/B) ratio is 2.57 compared to its sector average of 1.78
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada.
Based in Northbrook, the company has 55,000 full time employees and a market cap of $51.44 Billion. Allstate currently returns an annual dividend yield of 1.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.